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Regulation of the phd/doc toxin-antitoxin operon
involves the toxin Doc as co- or derepressor depend-
ing on the ratio betweenPhd andDoc, a phenomenon
known as conditional cooperativity. The mechanism
underlying this observed behavior is not understood.
Here we show that monomeric Doc engages two Phd
dimers on two unrelated binding sites. The binding
of Doc to the intrinsically disordered C-terminal
domain of Phd structures its N-terminal DNA-binding
domain, illustrating allosteric coupling between
highly disordered and highly unstable domains.
This allosteric effect also couples Doc neutralization
to the conditional regulation of transcription. In this
way, higher levels of Doc tighten repression up to
a point where the accumulation of toxin triggers the
production of Phd to counteract its action. Our
experiments provide the basis for understanding
the mechanism of conditional cooperative regulation
of transcription typical of toxin-antitoxin modules.
This model may be applicable for the regulation of
other biological systems.INTRODUCTION
Regulation of gene expression is a fundamental process that
allows a cell to respond to changes in its environment. At the
molecular level, expression is tuned by the concerted action of
both activators and repressors, whose activities are typically
linked to internal or external stimuli (Lawrence, 2003). Bacterial
toxin-antitoxin (TA) operons form small regulatory networks
that are repressed under unrestrained growth conditions and
activated during episodes of nutritional stress (Buts et al.,
2005; Gerdes et al., 2005). The phd/doc antitoxin-toxin operon
from bacteriophage P1 contributes to the perpetuation of theplasmid-prophage inside E. coli. The toxin Doc inhibits transla-
tion by blocking the ribosomal A site (Liu et al., 2008). This poten-
tially lethal activity of Doc is controlled by the action of its
antitoxin Phd. The C-terminal domain of Phd is intrinsically disor-
dered in solution and folds into an a helix upon binding to Doc
(Garcia-Pino et al., 2008). The N-terminal domain of Phd is
a dimerization domain that binds to DNA and represses the
transcription of the operon.
A hallmark of TA operons is autoregulation of transcription by
the gene products (Gerdes et al., 2005). The molecular mecha-
nism for the regulation of these TA modules remains elusive.
Because of its short in vivo half-life, the antitoxin population
must be continuously restored to prevent activation of the toxin
(Gerdes et al., 2005). Both events, the increase in the levels
of free toxin and the increment in antitoxin production, are
linked through the dual behavior of the toxin as a transcription
enhancer/corepressor, depending on the molar ratio over the
antitoxin, an unexplained phenomenon termed conditional co-
operativity (Afif et al., 2001; Magnuson and Yarmolinsky, 1998;
Overgaard et al., 2008).
The apparent simplicity of the three-component network
formed by toxin, antitoxin, and their operator DNA contrasts
with the complex set of interactions underlying proper func-
tioning of TA modules. To gain insights into this regulatory
processwe determined the crystal structure of the unbound anti-
toxin Phd and its complex with the toxin Doc from the phd/doc
TA module of bacteriophage P1 (Lehnherr et al., 1993). These
structures provide a framework to understand how Phd/Doc
complexes of variable stoichiometry can be formed and how
modulation of the Phd:Doc stoichiometry affects DNA binding
and repression.
RESULTS
The Phd N-Terminal Domain Adopts Two Different
Folding States
Phd crystallizes in two different crystal forms. Form I contains
a version of the protein that is truncated at Ser58 (hereafterCell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc. 101
Figure 1. Crystal and Solution Structure
of Phd
(A) Structure of the dimeric Phd N-terminal domain
(residues 1–57) in its folded conformation as
observed in both crystal forms. A 210 A˚3 cavity
at the center of the hydrophobic core is contoured
by a blue chicken wire.
(B) Conformations adopted by the C-terminal
domain of Phd. The three conformations in blue
are the distinct conformations observed in crystal
form II. The fully a-helical conformation shown in
green is representative for the molecules in crystal
form I. The conformation shown in yellow corre-
sponds to an unbound state in the Phd/Doc coc-
rystals. The orange and red models correspond
to the conformations bound to the L and H sites
of Doc, respectively.
(C) Structure of the partially unfolded conforma-
tion of the N-terminal domain observed in crystal
form II.
(D) Comparison of the experimental scattering
profile of Phd with the one computed from the
crystal structures (foldeddimer inblue line; partially
unfolded dimer in orange) and the profile corre-
sponding to the ensemble selected by EOM (red
line). The inset shows theKratky plot (I$s2 versus s).
(E) Variation of the R2/R1 ratios with the residue
number for the Phd ensemble in solution (red
bars) and those calculated for the folded confor-
mation based on the crystal structure (repre-
sented as gray bars). The secondary structure
elements of the N-terminal domain as observed
in the crystal structure, are show as an inset.
(F)Mappingof thebackbone 15N relaxation data on
the structure of Phd1-57. The ‘‘dynamic hot spots’’
involved in conformational exchange (based on
the R2/R1 data) are colored in red, and the regions
involved in fast dynamics (based on the heteronu-
clear NOE data) are colored in purple.
See also Figure S1 and Table S1.termed Phd1–57). All four molecules in the asymmetric unit adopt
a similar, well-folded conformation encompassing Met1-Phe56.
This N-terminal domain forms a small globular homodimer
comprising a central six-stranded b sheet decorated with four
a helices (two from each monomer), resembling the antitoxin
YefM (Kamada and Hanaoka, 2005) (Figure 1A; Figure S1A avail-
able online). The N-terminal a helices a1 and a2 form a large
positively charged surface that constitutes the DNA-binding
region (Figure S1B). The dimer interface is relatively small (about
900 A˚2 of water accessible surface buried per dimer). Interaction
of b strands b3 (Ala36-Ser40) from both monomers with each
other and with helices a1 and a2 accounts for most of the hydro-
phobic core of the protein, which runs through the dimer inter-
face and consists only of a number of small aliphatic side chains.
A rather unusual feature of the Phd hydrophobic core is the pres-
ence of a relatively large cavity (about 210 A˚3, Figure 1A).
At the C termini of strand b3, a third set of a helixes emerges
that connects the N-terminal domain to the intrinsically disor-
dered C-terminal region. The a helices a3 from both monomers
cross at an angle of about 60, creating a second small hydro-
phobic core distinct from the main hydrophobic core of the
N-terminal domain. This arrangement, with Phe44 shielded by102 Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc.Tyr47 and an intermolecular salt bridge formed between Glu25
of one monomer and Lys48 of the other (Figure S1C) is likely to
further stabilize the Phd dimer.
Crystal form II on the other hand contains two distinct confor-
mations of full-length Phd entrapped in the same single crystal
lattice. The first conformation is highly ordered, with the
N-terminal domain having a conformation essentially indistin-
guishable from the one observed in crystal form I. The C-terminal
domain (Ala57-Arg73) of this dimer is also structured due to
lattice interactions (Figure 1B; Figure S1D). The conformations
adopted by the C terminus are distinct from each other and
from the Doc-bound conformations (see below). They contain
variable amounts of a helix and likely sample the conformational
ensemble of the Phd C-terminal domain in solution.
The second conformation observed in crystal form II is a
partially unfolded one (Figure 1C). Whereas the b sheet core
remains essentially intact (with b strands b1, b2, and b3 as the
sole elements of regular secondary structure), the surrounding
a helices almost completely unwind (Figure 1C). The residues
from a helix a1 become disordered whereas those originating
from a helix a2 adopt a loop conformation. Residues belonging
to helices a1 and a2 are likely to constitute the operator binding
Figure 2. Stability and Interactions
(A) CD spectrum of free Phd (in blue) and bound to DNA (red) after correcting for buffer effects and subtracting the contribution of the DNA to the CD signal.
(B) Stability of Phd expressed in terms of its free energy of denaturation. Free Phd is shown in red, the complex with DNA in blue, and the complex with Doc in
orange.
(C) Binding of Phd to wild-type Doc monitored with SPR. Black lines represent the best fit of the model function (which assumes two independent Phd-binding
sites) to the experimental data (red lines).
(D) ITC titrations of Phd51–73 to Doc (left), DocH66Y/A61R (middle), and DocH66Y/N78W (right).
See also Figure S2, Table S2, and Table S4.site as mutations that change operator DNA specificity map in
this region (Zhao and Magnuson, 2005). Therefore the partially
unstructured conformation of Phd is probably not capable of
binding to the phd/doc operator site. Indeed, a helix is induced
in Phd upon addition of operator DNA in vitro (Figure 2A).
Phd Adopts a Heterogeneous Conformational Ensemble
in Solution
To further understand the nature of the Phd conformational
ensemble in solution, we used small-angle X-ray scattering
(SAXS) and nuclear magnetic resonance (NMR). Analysis of the
SAXS data strongly suggests the presence of conformational
heterogeneity in solution. The plateau at I(s)s2 > 0 observed in
the Kratky plot (Figure 1D) indicates that Phd is partially unstruc-
tured (Pollack et al., 1999; Porod, 1982), in agreement with earlier
circular dichroism (CD) studies (Gazit and Sauer, 1999). The
disorder indicated by the SAXS data is consistent with the high
flexibility of Phd in the crystal. However, the theoretical scat-
tering curve computed from both types of dimer (ordered or
disordered) observed in the crystal structures is insufficient to
fit the experimental SAXS data (Figure 1D).
Intrinsic disorder of theC-terminal domain is amain contributor
to protein heterogeneity as determined by SAXS. Using the
ensemble optimization method (EOM) (Bernado et al., 2007),
we find that the scattering curve can be modeled assuming
a fixed conformation for residues 1–40 of Phd and a wide
structural ensemble for residues 41–73 (c2 = 0.8, Figure 1D,
Table S1). Thus the conformational heterogeneity observed in
the N-terminal domain does not significantly affect its overallshape. A subset of the selected ensemble illustrating the struc-
tural diversity of the population is shown in Figure S1E. This
ensemble is consistentwith the lackof secondary structureprevi-
ously observed in the CD spectrum of the C-terminal domain of
Phd (Garcia-Pino et al., 2008).
We used NMR to characterize the structure of the N-terminal
domain of Phd (Phd1–57—residues 1–57) in solution. This
N-terminal domain of Phd examined by two-dimensional (2D)
1H-15N HSQC NMR is in agreement with a conformationally
heterogeneous protein that populates folded and disordered
states (Figure S1F, in cyan). However, at low ionic strength, the
protein is stabilized in a state that allows the assignment of the
1H-15N cross-peaks (Figure S1F, in blue).
When attempting to probe the flexibility of Phd1–57 with
hydrogen-deuterium exchange experiments, virtually all amide
protons exchange within the set-up time (11 min) prior to the
start of NMRacquisition, and their 1H-15N cross-peaks are there-
fore absent in the HSQC spectrum. Such dramatic behavior
indicates very low stability and lack of conformational rigidity
and is presumably the result of a high overall conformational
exchange of Phd between folded and partially folded states
(See Extended Experimental Procedures for further details).
In order to better characterize the dynamics of the N-terminal
domain of Phd, we next measured 15N backbone relaxation
rates. The heteronuclear Nuclear Overhauser Effect values
(hNOE), probing extensive high-frequency motions on the ps
to sub ns timescale, are almost all lower than the minimal
value of 0.86 at 800 MHz expected for a rigid globular protein
(Figure S1G).Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc. 103
Given the expected elevated conformational heterogeneity of
Phd1–57, the 15N transverse and longitudinal relaxation rates (R2
and R1) are the best indicators to probe the state of the Phd
1–57
ensemble in solution. Figure 1E shows the R2/R1 ratios along the
Phd1–57 sequence (represented as red bars). Two regions show
significantly high R2/R1 ratios as a result of elevated R2 rates,
indicative of a pronounced conformational freedom and high
exchange between different conformational states in the ms to
ms timescale. Additionally the C-terminal region displays
pronounced low R2/R1 ratios, which indicate an increase in fast
dynamics (i.e., high degree of flexibility) in agreement with the
heteronuclear NOE values found for this region of the domain
(Figure S1G). More significantly, when we map the R2/R1 data
on the X-ray structure of Phd (Figure 1F), the ‘‘dynamic hot
spots’’ correspond to a helices a2 and a3, two regions that
lose structure in the partially disordered conformation observed
in the X-ray structure.
The dynamic nature of Phd1–57 in solution becomes evenmore
apparent when we compare the experimentally determined R2/
R1 ratios for the Phd
1–57 solution ensemble with those calculated
theoretically using the coordinates of the crystal structure of the
folded protein (Figure 1E). In the folded conformation the pre-
dicted R2/R1 pattern is significantly more uniform throughout
the entire domain and the values for a helices a2 and a3 are close
to the average. By contrast the solution ensemble contains
‘‘dynamic hot spots’’ that are involved in significant conforma-
tional exchange, and the C-terminal region (a helix a3 in the
folded conformation) is disordered. Only the b sheet core of
the protein retains a more folded behavior, exactly as we
observed in the crystal structure of the partly folded species
(Figures 1C and 1F).
Operator DNA and Doc Binding Lead to Structuring
of Phd
Differential scanning calorimetry (DSC) unfolding data of Phd
and its N-terminal fragment Phd1–57 fit well to a two-state model
consisting of a dimer unfolding into monomer species. In its
unbound state Phd is only marginally stable (Figure 2B). The
unfolding endotherms of both the full-length protein and the
deletion mutant Phd1–57 are virtually identical and characterized
by marked broadening and very low heat of denaturation
(Figures S2A–S2B and Table S2). This indicates a poorly struc-
tured unfolding unit, suggesting that, in agreement with the
NMR data, the partly unfolded species dominates in solution.
In addition, the sizable cavity in the hydrophobic core of the
folded state of the N-terminal domain is expected to contribute
to its low thermodynamic stability.
Earlier studies indicated that operator DNA binding increases
the melting temperatures of several TA antitoxins (Gazit and
Sauer, 1999; Madl et al., 2006; Oberer et al., 2007). Our DSC
measurements show that binding of DNA or of its toxin partner
Doc to Phd significantly increases its thermodynamic stability
(Figure 2B, Figure S2C, and Table S2). In both cases the incre-
ment in the conformational stability is accompanied by a large
increase in the heat of unfolding and the melting temperature
of Phd. Both binding events also coincide with an increase
in a-helical content as observed by CD spectroscopy for the
Phd-operator DNA complex (Figure 2A) and by X-ray crystallog-104 Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc.raphy and SAXS for the Phd/Doc complexes (see below). These
results support our conclusion that the population ensemble
equilibrium shifts toward a more ordered conformation of the
N-terminal domain upon binding, coupling stabilization to the
increment of the repression-compatible subpopulation of Phd.
The Secondary Hydrophobic Core of Phd Affects DNA
Binding
Mutations within a helix a3 in the central region of Phd strongly
affect DNA binding. Whereas the wild-type dimer clearly
occupies two binding sites consecutively (Figure 3A), the F44A,
Y47A, and K48M mutants show a significant reduction of DNA-
binding capacity in vitro (Figure S3A). PhdF44A and PhdY47A
were also shown to affect the repressor activity of Phd in vivo
(McKinley and Magnuson, 2005 and Table S3). As the region of
Phd harboring these residues is unlikely to come in direct contact
with DNA, the mutations are expected to act through a global
destabilization of the protein by disturbing the small secondary
hydrophobic core of Phd. Indeed, CD spectra of these mutants
indicate that they are significantly less structured than the wild-
type protein (Figure S3B).
In contrast, all Phd mutants retain their ability to bind and
inhibit Doc (Figure 3C). Wild-type Phd fully inhibits the effect of
Doc on translation of the mRNA encoding E. coli EF-Tu when
present at a 1:1 ratio to Doc. The effects of Phd mutants F44A,
Y47A, andK48Mon in vitro translation of EF-Tu are indistinguish-
able from that of the wild-type protein. The latter is not surprising
as all mutations are located outside the Doc-interacting segment
of Phd and as the C-terminal segment (residues 50–73) on its
own is sufficient for inhibiting Doc activity in vitro and in vivo
(McKinley and Magnuson, 2005; Smith and Magnuson, 2004).
Thus the formation and stabilization of the small hydrophobic
core of Phd has a pivotal role in the exchange between unbound
and DNA-bound conformations. The stabilization of this struc-
ture tilts the equilibrium in the direction of the folded (DNA-
binding compatible) state, whereas mutations destabilizing
a helix a3 shift the equilibrium toward the disordered low-DNA
affinity state.
Long-Range Allosteric Interactions Couple Toxin
Binding to Operon Regulation
Doc-mediated enhancement of Phd binding to operator DNA is
observed in operator regions containing a single Phd-binding
site (Figures 3D–3F), in agreement with earlier observations
(Magnuson and Yarmolinsky, 1998). The effect of Doc on the
affinity of Phd for a single DNA-binding site (OR1) was quantified
using isothermal titration calorimetry (ITC). The affinity of
Phd2Doc for OR1 is 0.3 mM, about 10-fold higher than the binding
constant of Phd2 for OR1 (Figures 3D and 3E; Table S4). Thus
binding of Doc to the intrinsically disordered C-terminal region
of Phd allosterically affects the activity of the N-terminal binding
domain. Allosteric coupling involving disordered domains has
been hypothesized before (Hilser and Thompson, 2007) but
never observed experimentally.
Given that helixa3of Phd is located adjacent to itsDoc-binding
region and that mutations within this helix affect operator DNA
binding in vivo and in vitro, we investigated if suchmutantswould
also affect Doc-mediated enhancement of the Phd-operator
Figure 3. Interplay between Phd, Doc, and the Operator DNA
(A) EMSA of wild-type Phd binding to OR1/2. Lane 1 contains only OR1/2, and lanes 2–7 contain Phd in increasing amounts (0.025, 0.05, 0.1, 0.5, 1.0, and 10.0 mM,
respectively). Bands marked F and P correspond to free DNA and Phd-bound DNA, respectively. Mutations in Phd uncouple Doc binding from DNA binding.
(B) EMSA of Phd in complex with wild-type Doc, showing the typical supershifting band pattern due to the formation of Phd/Doc/OR1/2 complexes with different
stoichiometries. The Doc/Phd ratios used in each lane are indicated. The Phd concentration was kept constant at 100 nM. Bandsmarked F, P, and C correspond
to free DNA, Phd-bound DNA, and Phd/Doc-bound DNA, respectively.
(C) Doc activity assay based on the in vitro translation of E. coli elongation factor EF-Tu (lane 1). Lanes 2 and 3 show the effect of free wild-type Phd and wild-type
Doc, respectively. Lanes 4, 5, 6, and 7 show the effect of wild-type Phd, PhdF44A, PhdY47A, and PhdK48M, respectively, in presence of Doc (all protein concen-
trations 250 nM).
(D) Binding of Phd to OR1 monitored by ITC.
(E) ITC titration of OR1 to the Phd/Doc complex (prepared by mixing the corresponding Phd and Doc amounts, to obtain Phd2-Doc as the predominant species).
(F) Effect of Doc on the interaction of Phd, PhdF44A, PhdY47A, and PhdK48Mwith a DNA fragment containing one binding site (OR1). Phd was used at 50 nMwhereas
the mutants were used at 1 mM. In all cases Doc was added in equimolar amounts. The labels C, P, and F are as in (B).
Further details are given in Figure S3, Table S3, and Table S4.DNA affinity. Phd mutants F44A and Y47A bind to Doc, but this
does not lead to an increase of the affinity of the Phd mutant for
OR1 (Figure 3F), indicating disruption of the communication
between the N- and C-terminal domains of Phd. Thus these
mutations uncouple the Doc-binding and operator DNA-binding
activities of Phd and pinpoint helix a3 of Phd as a communication
channel between its N- and C-terminal domains.
Phd mutant K48M on the other hand shows an intermediate
behavior in terms of Doc binding and the corresponding
enhancement in DNA binding. Despite its low intrinsic affinity
for DNA, which is similar to PhdF44A and PhdY47A, this mutant
shows weak but observable enhancement of Phd2 binding to
OR1 in the presence of Doc (Figure 3F), indicating that the effects
observed for PhdF44A and PhdY47A are not a consequence of
their weak DNA binding potential per se.
Doc Possesses Two Nonidentical Binding Sites for Phd
The asymmetric unit of our Phd/Doc cocrystals contains three
copies of Phd and one copy of Doc, which through crystal
symmetry form a hetero-octameric Phd2-Doc-Phd2-Doc-Phd2
complex (Figure 4A; Figure S4A). Alternating units of toxin and
antitoxin molecules bound to DNA were predicted from
biochemical data for the ccd operon (Dao-Thi et al., 2002) and
have been observed using native mass spectrometry experi-
ments in themazEFmodule (Monti et al., 2007). The architecture
of the Phd/Doc complex, however, is quite unique. A monomericDoc toxin possesses two binding sites (termedH and L hereafter)
that recognize the Phd C-terminal segment in distinct conforma-
tions, thereby bridging two antitoxin dimers.
About 25% of the surface of Doc is buried upon interacting
with two Phd dimers (Figure 4B). Site H corresponds to the
one identified earlier in the crystal structure of a nontoxic mutant
of Doc (Garcia-Pino et al., 2008) and recognizes the Phd
segment Phe56-Arg73. This site encompasses residues from
a helices a1, a4, a5, and the loop a4-a5 of Doc (Figure 4B) and
represents the most extensive contact interface between toxin
and antitoxin (1024 A˚2 are buried).
Site L is located on the opposite side of Doc (Figure 4B) and
mainly encompasses residues from loops a1-a2 (residues
28–31) and a5-a6 (residues106–111) and from helices a2
(34–35, 38–39, 42) and a3 (57–61, 64–65). This site forms
a shallow hydrophobic indentation on the surface of the protein
and accommodates residues Leu52-Thr62 of Phd in an a-helical
conformation. The side chains of Leu52, Phe56, Leu59, and
Phe60 of Phd provide the most extensive contacts to Doc.
This binding surface on Doc is fenced by the charged residues
Asp28, Arg31, Arg38, Arg42, and Arg64. This ‘‘electro-positive
fence’’ interacts with the hydrophilic part of the amphipathic
C terminus of Phd, tethering the Phd C-terminal a helix to the
surface. The total area buried upon complex formation (650 A˚2)
is much smaller, resulting in marked differences in affinities
between both sites.Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc. 105
Figure 4. Phd/Doc Complexes
(A) Crystal structure of the Phd2-Doc-Phd2 complex. The complex consists of
two Phd dimers (themonomers that form each dimer are colored in orange and
red) wrapped around a Doc monomer (in blue).
(B) Mapping on the surface of Doc, of the residues that form the two Phd-
binding sites. Residues that form the high-affinity site (site H) are colored in
blue, whereas residues located in the low-affinity site (site L) are colored in
green. In both cases, a stereo representation with the details of the interactions
with Phd is shown next to each site.
(C) SAXS structure of the Doc-Phd2-Doc complex. The dimensions of this rigid
complex prevent the binding of two of such particles at the same time on the
operator DNA.
See also Figure S4 and Table S1.The distance between two equivalent residues from the Doc-
bridged Phd dimers is approximately 43 A˚ (Figure 4A), matching
the separation of equivalent bases of the two palindromes of the
phd/doc operator region recognized by Phd (assuming B-DNA).
This suggests that the conformation of the complex observed in
the crystal structure closely resembles the one that binds on the106 Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc.promoter region and represses the transcription of the phd/doc
operon.
Using surface plasmon resonance (SPR), we measured the
binding kinetics and affinities for both interaction modes
between Phd and Doc (Figure 2C). Consistent with the crystal
structure of the complex, the best model that explains the
binding data involves two Phd dimers binding to a Docmonomer
with affinities of 0.35 mM and 31 mM (Figure 2C; Table S4). These
features were further confirmed by ITC measurements
(Figure 2D and Table S4) of wild-type Doc and the C-terminal
Doc-neutralizing domain of Phd (Phd51–73). Moreover we also
measured the interaction of the DocH66Y/A61R and DocH66Y/N78W
mutants with Phd51–73. The affinities obtained for the mutants
pinpoint site H as the high-affinity site and site L as the low-
affinity site, in agreement with their difference in contact surface
area.
Phd and Doc Form a Series of Distinct Complexes
When Bound to Operator DNA
Doc modulates the affinity of Phd for the operator region of the
operon as observed in electrophoretic mobility shift assays
(Figure 3B). At increasing Doc:Phd ratios between 0 and 1, the
band corresponding to unbound DNA disappears and a series
of distinct bands appear that we interpret in terms of Phd/Doc/
DNA complexes of variable stoichiometry. A first Doc molecule
will bridge the two Phd dimers bound to their two sites on the
operator DNA and increase affinity through an avidity effect.
This interaction will recruit both the high- and low-affinity sites
on Doc. A second and third Doc molecule will bind through their
high-affinity sites on the two free Phd C termini of the DNA-
bound Phd2-Doc-Phd2 complex, resulting in a Doc-Phd2-Doc-
Phd2-Doc operator DNA complex.
Additional molecules of Doc, however, cannot interact without
disturbing this repressor complex. Indeed, when the Doc:Phd
ratio exceeds 1, the operator complexes apparently resolve.
The remaining affinity for what is probably a Doc-Phd2-Doc
complex interacting only via the H sites drops to a level compa-
rable to that of Phd in absence of Doc.
When tested on the full operator region (OR1/2), the two Phd
mutants PhdF44A and PhdY47A that lack allosteric coupling
between their N- and C-terminal domains create in the presence
of Doc a similar series of distinct DNA complexes as observed for
wild-type Phd (Figure S3C). The enhancement in affinity due to
bridging of Doc is nevertheless much weaker than what is
observed for wild-type Phd, indicating the importance of the
communication between both Phd domains for autoregulation
and an interplay between the allostery and avidity effects of
Doc. Derepression at high Doc to Phd ratios does not seem to
be affected by these mutations.
Both Phd-Binding Sites on Doc Are Essential
for the Autorepression
In order to validate the role of both Phd-binding regions on Doc,
we designed point mutants individually affecting the two binding
sites of Doc and analyzed their behavior in vivo and in vitro. As
mutations in one or both of the binding sites may lead to uncon-
trolled toxicity of Doc, these experiments were carried out in
a nontoxic DocH66Y background to facilitate the production of
Figure 5. The Two Phd-Binding Sites in Doc Are Involved in the Formation of the Repressor Complex
(A) EMSA showing the effect of the Doc mutants H66Y, H66Y/N78W, and H66Y/A61R on the interaction of Phd with OR1/2. The Phd complex with Doc
H66Y inter-
acts with OR1/2 in a wild-type-like manner, whereas the Phd complexes with Doc
H66Y/N78W and DocH66Y/A61R result in a less complex pattern of bands. The
Doc:Phd ratio is given above each lane. Concentrations used are identical to those for Figure 3B. Bands marked F, P, and C correspond to free DNA, Phd-bound
DNA, and Phd/Doc-bound DNA, respectively.
(B) In vivo corepression assays. Corepression activity was indicated by the ability of the test construct to corepress transcription of a lacZ reporter fused to the
promoter of the P1 addiction operon.
(C) In vivo competition assay. The competition assaywasmonitored by the ability of the test construct to compete with wild-typeDoc for binding to wild-type Phd,
resulting in loss of cell viability. Bars represent the average of triplicate measurements ± standard error.
Details of the corepression and competition assays are given in the Table S5.the proteins. Themutation H66Y in Doc does not affect the struc-
ture of the protein (Garcia-Pino et al., 2008) nor Phd binding
(Table S4). Furthermore, wild-type and DocH66Y show indistin-
guishable patterns of band-shifting in our EMSA assay, indi-
cating that both proteins enhance the Phd-DNA interaction in
an identical manner (Figure 3B and Figure 5A).
The N78Wmutation was selected to knock out site H whereas
A61R was chosen to knock out site L. These mutations are
located on the surface of Doc and do not affect the overall
structure of the protein as assessed by CD spectroscopy
(Figure S3D). Their Phd-binding activities were confirmed using
ITC (Figure 2D—see above). Both mutants show a less complex
set of bands in EMSA experiments in agreement with the pres-
ence of only one functional site, indicating that both sites are
indeed recruited in the wild-type operator complex but not in
the mutant complexes (Figure 5A).
We further validated the role of site L in autoregulation (again in
a nontoxic DocH66Y background) in vivo using a lacZ repression
assay and through an indirect toxicity assay that reports the
presence of a functional site H (see Extended Experimental
Procedures for details). Knocking out site L is expected to resultin a Doc phenotype unable to act as corepressor but still capable
of binding Phd through site H. As expected, most mutants
(R31A, R31D, I35A, R38A, R38D, A61W, A61D, R64E, and
R64W) show a decreased corepression activity (Figure 5B;
Table S5), remaining, however, capable of displacing wild-type
Doc from site H. This effect is severely marked for the mutants
R38D and A61D (in agreement with our in vitro results). These
site L mutants disrupt the interaction of Phd with Asp53 (in the
case of the R38D mutation) or introduce a negative charge in
the hydrophobic pocket that accommodates residues Phe56
and Phe60 of Phd (for A61D) and results in a complete loss of
corepression. However, their ability to bind Phd through their H
site remains intact (Figure 5C; Table S5). Thus the low-affinity
interaction that is required to establish a Doc-bridge between
two operator-bound Phd dimers is crucial for Doc-mediated
enhancement of repression.
Solution Structure of the Doc-Phd2-Doc Complex
Our mechanistic model for conditional cooperativity predicts
that at saturating levels of Doc, a Doc-Phd2-Doc heterotetra-
meric complex that is far less capable of repressing the phd/docCell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc. 107
Figure 6. Model for the Regulation of the phd/doc Operon
Phd exists in two conformational states: ordered or disordered. Only the
ordered state is capable of binding to DNA. In the absence of Doc, DNA
binding by Phd is weak and the operon remains unrepressed. Binding of
Doc structures Phd and results in higher affinity binding to the operator
DNA. The two distinct Phd-binding sites in Doc (L and H) allow Doc to form
a bridge between two Phd dimers, resulting in repression of the operon.
Two additional Doc molecules can bind to this complex via the two remaining
free C termini of Phd. A fourth molecule of Doc, however, will resolve the oper-
ator complex by exchanging an L site interaction by an H site interaction,
resulting in derepression. Proteolytic degradation of Phd under activating
conditions such as nutritional stress will free Doc and allow it to bind to the
A site of the ribosome to inhibit translation. Fresh Phd can rescue the ribosome
and the resulting complex will again repress the phd/doc operon.
See also Figure S5.operon is formed. We used SAXS to characterize this complex
and examine its shape and dimensions. Based on our crystal
structure, we constructed a series of alternative Phd/Doc
complexes with different stoichiometries (including Phd2-Doc-
Phd2, Doc-Phd2-Doc, and the two possible Phd2-Doc architec-
tures). The comparison of the experimental scattering data to
the calculated scattering curves derived from these models
reveals a close correspondenceonly to theDoc-Phd2-Docmodel
and very poor fits to other architectures (Table S1). The Rg
(27.5 A˚) calculated from the Guinier analysis and the bimodal
shape and maximum dimension of the particle (Dmax = 85 A˚)
obtained from the distance distribution function (P(r)) all agree
with our V-shaped model of the Doc-Phd2-Doc complex. More-
over theP(r) functionandKratkyplotareconsistentwithaproperly
folded, homogeneous, and well-structured species (Figures
S4B–S4C).
To provide additional support to the models obtained by rigid
body fit, we used the program DAMMIF for ab initio SAXS shape
reconstruction of the complex. No constraints were imposed on
the simulated annealing refinement protocol. All themodels were
very reproducible in independent runs with average normalized
spatial discrepancy (NSD) values below 1.0. These models are
highly consistent with our pseudo-atomic model of the complex
and show the same V-shaped structure (Figure 4C).
Docking of our pseudo-atomicmodel on the phd/doc operator
site shows that two Doc-Phd2-Doc entities cannot bind simulta-
neously to the two operator sites due to steric overlap. Thus
steric exclusion provides the mechanism for derepression at
high Doc:Phd ratios.
A Model for the Regulation of the Phd/Doc Operon
Our combined structural and biochemical data allow us to put
forward for the regulation of the phd/doc operon a model that
explains conditional cooperativity (Figure 6). We propose that
a monomeric Doc molecule, capable of interacting with two
Phd dimers simultaneously, acts as a bridge between two Phd
dimers, increasing the avidity of Phd for DNA and thus enhancing
the repression of the operon.
In this arrangement, both the H and L sites of Doc are occu-
pied and both Phd dimers retain a free toxin-binding site. These
free sites will act as buffers that can trap additional Doc mole-
cules through their H sites. Further increase in the ratio of Doc
to Phd will ultimately outcompete the low-affinity L sites of Doc
in favor of the high-affinity H sites, resolving the repressor
complex. The resulting alternative nonrepressing Doc-Phd2-
Doc complex is a rigid entity that for steric reasons cannot
occupy both sites on the operator DNA. Therefore high Doc:Phd
ratios, which are dangerous for the cell, will result in transcription
of the operon and production of Phd, after which repression is
again established. Only in the case where the P1 plasmid is
lost will the proteolytic degradation of Phd release Doc in suffi-
cient amounts to block translation indefinitely by binding to the
A site of the ribosome and cause cell death.
Additional cooperativity in the system arises from prestructur-
ing of the DNA-binding domain of Phd by binding of Doc units.
The crystal and solution structures of Phd suggest the coexis-
tence in solution of a partially disordered Phd dimer ensemble
in equilibrium with a more ordered, DNA-binding-competent108 Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc.population. The addition of Doc shifts this equilibrium toward
the DNA-competent conformation, increasing the affinity of the
Phd for its operator DNA.
Thus the system relies on intrinsic disorder not only to allow
Phd to bind to two distinct sites on Doc but also to modulate
the intrinsic affinity of Phd for its operator DNA and to separate
the neutralization function of Phd from its regulatory func-
tion. The high-affinity site safeguards the cell from the action of
free toxin whereas the low-affinity site is essential for the
cooperative binding to DNA and for switching from repression
to derepression.
DISCUSSION
Allosteric Coupling and Intrinsic Disorder
Allostery is an essential part of many if not most nonstructural
proteins, and in particular of regulatory proteins. A second
general feature of regulatory proteins, especially in eukaryotes,
is the prevalence of intrinsic disorder. A link between both
properties has been suspected and a theoretical framework
explaining how intrinsic disorder can increase allosteric coupling
between two contacting domains has been proposed (Hilser and
Thompson, 2007). Our studies on Phd provide direct experi-
mental evidence demonstrating allosteric coupling between
two domains displaying different degrees of disorder. The
N-terminal domain of Phd exists in solution as an equilibrium
between a DNA-binding-competent ordered state and a DNA-
binding-incompetent, highly unstable state. The equilibrium
between both states is influenced not only by its direct ligand,
the operator site, but also by binding of the Doc corepressor to
the intrinsically disordered C-terminal segment of Phd.
It was predicted that site-to-site coupling would bemaximized
when a well-defined pathway of folded structure connects the
two sites (Hilser and Thompson, 2007). Such a pathway is indeed
present within Phd and involves a set of specific interactions at
the boundary between both communicating domains. Binding
of Doc to the C-terminal segment of Phd results in the formation
of an a helix that extends into helix a3 of its N-terminal domain. In
this way, a3 is stabilized and this stabilization propagates
through the small hydrophobic core of the protein over the whole
N-terminal domain including the DNA-binding site.
A query of the Protein Data Bank (PDB) revealed three
additional proteins that adopt a similar fold: E. coli YefM, the
N-terminal domain of M. tuberculosis YefM, and an N-terminal
fragment of a transcriptional regulator from N. europaea
(Kamada and Hanaoka, 2005; Kumar et al., 2008). All these
proteins show a well-conserved fold despite very little sequence
identity. The two key structural features of the linking region that
mediates allosteric communication in Phd are nevertheless
present in each of them: a small hydrophobic core typically
shielded by two aromatic side chains contributed by each helix
a3 and a network of salt bridges that tethers N- and C-terminal
domains (Figure S5). This observation validates this structural
motif as functionally relevant and suggests a general stability-
based allosteric switch for the members of the Phd/YefM
superfamily.
Intrinsic Disorder in a Prokaryotic Transcription
Regulator
Much of the knowledgewe have about regulation of transcription
in prokaryotes comes from two particularly well-studied sys-
tems: the Lac repressor-lac operon (Lewis et al., 1996) and
the l-repressor and l-Cro for the control of the lysogenic/lytic
cycles of l-phage (Albright and Matthews, 1998). In both cases,
the repressors are well-folded species lacking appreciable
structural disorder. Eukaryotic transcription factors on the other
hand are characterized by frequently possessing intrinsically
disordered segments or domains (Liu et al., 2006). Intrinsic
disorder, however, can be detected in the genomes of prokary-
otes as well, but its functional relevance is less well understood
(Dunker et al., 2002; Tompa, 2002). The insights obtained on
the regulation of the phd/doc operon pinpoint a mechanism
by which intrinsic disorder functions in prokaryotes and pro-
vide one of the few mechanistic studies on intrinsic disorder in
general.
A major discovery of this study is that the antitoxin Phd
binds to two different sites of a single Doc monomer through
its intrinsically disordered C terminus. These interactions showa 100-fold difference in affinity, allowing both the H and the L
sites on Doc to be occupied at high Phd:Doc ratios but the lower
affinity L site to be outcompeted at low Phd:Doc ratios. This
property is the core of regulation by conditional cooperativity,
which is general in toxin-antitoxin modules (Afif et al., 2001;
Magnuson and Yarmolinsky, 1998; Monti et al., 2007; Overgaard
et al., 2008). Transcription of TA operons is conditional to the
ratio between toxin and antitoxin and provides the cells with
a homeostatic mechanism to sense and respond to oscillating
levels of toxin. In absence of toxin, the antitoxin is only a weak
repressor and transcription of the operon occurs. At toxin:anti-
toxin ratios below 1, a repressing complex is formed by the
bridging of a toxin between two antitoxin proteins. The resulting
increase in affinity of the antitoxin for its operator DNA through
avidity is further enhanced by the structuring effect that the toxin
exerts on the DNA-binding domain of the antitoxin. At higher
toxin:antitoxin ratios, derepression occurs through a switch
from a low-affinity toxin-antitoxin interaction to a high-affinity
interaction, resulting in a complex with a different architecture
(Doc-Phd2-Doc) that is unable to efficiently repress the operon.
This mechanism of transcriptional control integrates intrinsic
disorder as a cornerstone of the regulatory process (a feature
previously considered only for eukaryotic proteins). The struc-
tural plasticity inherent to these proteins is a particular advan-
tage in the transmission of information. Signals can be trans-
mitted by a mere shift in the equilibrium population of states:
a single protein could deliver the signal to multiple targets,
turning the protein into a dynamic switch.A General Regulatory Mechanism?
The regulatory mechanism of phd/doc is likely to be general for
TA modules where conditional cooperativity seems to be a
general property. Indeed, the presence of repressor complexes
consisting of linear arrays of alternating antitoxin and toxin units
have been hypothesized for mazEF and ccdAB (Dao-Thi et al.,
2002; De Jonge et al., 2009; Monti et al., 2007). Furthermore,
the existence of toxin-antitoxin complexes with different stoichi-
ometry has been demonstrated for both mazEF and ccdAB (De
Jonge et al., 2009; Kamphuis et al., 2007).
Similar or related mechanisms may be at work outside the TA
context as well. Antitoxin DNA-binding domains belong to the
ribbon-helix-helix fold, the helix-turn-helix superfamily, the
AbrB superfamily, and the Phd/YefM superfamily, all well-known
families of prokaryotic transcription factors (Anantharaman and
Aravind, 2003). The attachment of a regulatory module at their
C termini in their TA-related versions (their toxin-binding
domains) results in an additional dimension in mechanistic
complexity, incorporating the toxin in the regulatory mechanism
as an anti/corepressor. Such segments that link a DNA-binding
protein to coregulatory elements may be present in a number
of other prokaryotic transcription regulators but still await identi-
fication.EXPERIMENTAL PROCEDURES
Structure Determination and Refinement
The structure of the Phd/Doc complex was determined by molecular replace-
ment using the coordinates of DocH66Y (PDB ID 3 dd7) as a search model inCell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc. 109
Table 1. Data Collection and Refinement Statistics
Phd/Doc
Complex
Free Phd
Form I
Free Phd
Form II
Data Collection
Space group P3221 C2221 P3121
Cell dimensions
a (A˚) 48.9 107.0 71.9
b (A˚) 48.9 122.5 71.9
c (A˚) 354.9 61.2 68.0
a () 90.0 90.0 90.0
b () 90.0 90.0 90.0
g () 120.0 90.0 120.0
Resolution (A˚) 42.0–2.40
(2.49–2.40)
34.0–2.20
(2.28–2.20)
12.0–2.25
(2.32–2.25)
Rsym or Rmerge 0.085 (0.224) 0.110(0.321) 0.074 (0.248)
I/sI 23.2 (10.8) 9.0 (6.9) 14.9 (6.7)
Completeness (%) 98.1 (97.8) 99.1 (99.9) 98.3 (93.1)
Redundancy 10.9 8.0 14.3
Refinement
Resolution (A˚) 2.40 2.20 2.25
No. reflections 19121 20810 9720
Rwork/Rfree 25.7/28.5 22.7/27.1 19.2/25.6
No. atoms
Protein 2438 3204 1181
Ligand/ion 4 30 —
Water 207 83 42
Rmsd
Bond lengths (A˚) 0.009 0.005 0.014
Bond angles () 1.288 0.777 1.597
Ramachandran profile
Core (%) 96.1 98.1 92.3
Allowed regions (%) 3.6 1.9 7.7
Outliers (%) 0.3 0 0
Deposition
PDB entry 3K33 3HS2 3HRYPHASER (McCoy et al., 2005). The structures of free Phd were determined by
molecular replacement using the N-terminal domain of Phd as present in the
Phd/Doc complex as search model. Refinement cycles using the maximum
likelihood target function of phenix.refine (Afonine et al., 2005) were alternated
with manual building using Coot (Emsley and Cowtan, 2004). The final cycles
included TLS refinement, with the optimal TLS groups calculated using the
TLSMD web server (Painter and Merritt, 2006). In every case, the final struc-
tures were validated with MolProbity (Davis et al., 2007). The statistics of the
refinement are shown in Table 1.
Surface Plasmon Resonance
Surface plasmon resonance (SPR) experiments were carried out on a
Biacore3000 system (GE Healthcare) at 25C in 20 mM HEPES (pH 7.5),
150 mM NaCl, 3 mM EDTA, 0.005% TWEEN-20 and a flow rate of 30 ml/min.
All the binding data were analyzed with the BIAevaluation 4.1 software.
Small-Angle X-Ray Scattering
SAXS data for free Phd and the Doc-Phd2-Doc complex were collected at
beamline X33 of the DESY synchrotron (Hamburg, Germany). The camera110 Cell 142, 101–111, July 9, 2010 ª2010 Elsevier Inc.length was 2.7 m and the wavelength 1.5 A˚, with 2 min of exposure time for
data collection. The data were averaged, background-subtracted, and
merged to generate the scattering curve with PRIMUS (Konarev et al., 2003).
The radius of gyration (Rg) was calculated from the Guinier analysis as imple-
mented in PRIMUS and also from the entire scattering curve with the indirect
Fourier transform package GNOM (Konarev et al., 2003, 2006). CRYSOL
(Svergun et al., 1995) was used to compare experimental and theoretical scat-
tering curves.
NMR Spectroscopy
For the backbone assignment of Phd1–57, a 15N/13C-labeled sample was
prepared for NMR experiments at 200 mM in 92% H2O, 8% D2O, 150 mM
NaCl, 0.1 M Arginine, 50 mM TRIS buffer at pH 7.5. NMR spectra were
recorded on a Varian NMR Direct-Drive Systems 800 MHz spectrometer using
a salt-tolerance triple-resonance cold-probe at 25C.
Isothermal Titration Calorimetry
All measurements were performed on a MicroCal VP-ITC calorimeter. The
samples were filtered and degassed for 30min at 298 Kbefore being examined
in the calorimeter. All measurements were done at 298 K, in 20 mM Tris
buffer (pH 7.5), 100 mM NaCl, and 1% glycerol. All data were analyzed using
MicroCal Origin DSC 7.0.
Electromobility Shift Assays
Binding of Phd to DNA fragments from the operon regulatory region (OR1/2 and
OR1) was followed bymobility shift electrophoresis (EMSA) as described (Gazit
and Sauer, 1999; Magnuson and Yarmolinsky, 1998). The mixture was incu-
bated for approximately 30 min at 20C and then electrophoresed on an 8%
polyacrylamide gel, which was later autoradiographed.
Please refer to the Extended Experimental Procedures online for further
details on the methods.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and five tables and can be found with this article online at doi:10.
1016/j.cell.2010.05.039.
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